Elixinol Wellness Ltd’s Oliver Horn speaks to Proactive following the news of a 53% improvement in EBITDA on the previous corresponding period – its best earnings result since the first half of 2019. Horn says they’ve continued to deliver on its strategy to build a consumer-centric, high margin branded consumer goods company. At the end of the period, Elixinol had nearly A$19 million in the bank to support its future operations.

source